Mag Stephan Strass > BRANDL TALOS Attorneys at law > Vienna, Austria > Lawyer Profile

BRANDL TALOS Attorneys at law
Rechte Wienzeile 223/14th floor
1120 Vienna

Work Department

Venture Capital & Start Ups | Corporate Law & Transactions | BioTech & Lifescience


Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.


Working Highlights:

Advising the shareholders of Allcyte on the sale to Exscientia
Advising the seller consortium, including Farallon, Global Health Investment Fund, Wellington Partners and Ventech on the sale of Themis to Merck Sharp Dohme
Advising numerous start-ups and other companies in the life sciences sector on university spin-offs and technology transactions
Advising Sportradar on its initial public offering on NASDAQ
Advising AC Immune on the acquisition of a vaccine candidate against Parkinson’s disease (Affiris)


University of Vienna, Faculty of Law (Mag. iur. 2015)
Harvard Law School, Master of Laws (LL.M. 2019)

Lawyer Rankings

Austria > Commercial, corporate and M&A

(Next Generation Partners)

Stephan Strass – BRANDL TALOS Attorneys at law

‘Delivering an outstanding service’, BRANDL TALOS Attorneys at law combines proficiency in corporate and capital markets law with particularly strong regulatory expertise. The practice is well known for high-quality advice in the gaming & entertainment sector, which is a specialism of Thomas Talos, who leads the team alongside Roman Rericha. Stephan Strass was promoted to partner in January 2023 and is described by clients as ‘one of the upcoming stars in the M&A market’.